Cynvec LLC

Immunotherapeutic in the Cancer space focusing at a IND approval for Ovarian Cancer. Currently raising funds to support this effort.

      • Presenter: Steven Blumenthal, CBO
      • Commercial Catalysts: Fred Banti and Phil Crowley
      • Defined Milestone: Strategically plan fund raise to support IND needs
      • Targeted Completion: 5 months